Literature DB >> 12502879

Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease.

Jarasvech Chinsangaram1, Mauro P Moraes, Marla Koster, Marvin J Grubman.   

Abstract

We have previously shown that replication of foot-and-mouth disease virus (FMDV) is highly sensitive to alpha/beta interferon (IFN-alpha/beta). In the present study, we constructed recombinant, replication-defective human adenovirus type 5 vectors containing either porcine IFN-alpha or IFN-beta (Ad5-pIFNalpha or Ad5-pIFNbeta). We demonstrated that cells infected with these viruses express high levels of biologically active IFN. Swine inoculated with 10(9) PFU of a control Ad5 virus lacking the IFN gene and challenged 24 h later with FMDV developed typical signs of foot-and-mouth disease (FMD), including fever, vesicular lesions, and viremia. In contrast, swine inoculated with 10(9) PFU of Ad5-pIFNalpha were completely protected when challenged 24 h later with FMDV. These animals showed no clinical signs of FMD and no viremia and did not develop antibodies against viral nonstructural proteins, suggesting that complete protection from infection was achieved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502879      PMCID: PMC140819          DOI: 10.1128/jvi.77.2.1621-1625.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Outbreak of foot-and-mouth disease virus serotype O in the UK caused by a pandemic strain.

Authors:  N J Knowles; A R Samuel; P R Davies; R P Kitching; A I Donaldson
Journal:  Vet Rec       Date:  2001-03-03       Impact factor: 2.695

2.  pAd5-Blue: direct ligation system for engineering recombinant adenovirus constructs.

Authors:  M P Moraes; G A Mayr; M J Grubman
Journal:  Biotechniques       Date:  2001-11       Impact factor: 1.993

3.  Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase.

Authors:  J Chinsangaram; M Koster; M J Grubman
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

4.  Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle.

Authors:  D Sa-Carvalho; E Rieder; B Baxt; R Rodarte; A Tanuri; P W Mason
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways.

Authors:  A Zhou; J M Paranjape; S D Der; B R Williams; R H Silverman
Journal:  Virology       Date:  1999-06-05       Impact factor: 3.616

6.  Manipulation of adenovirus vectors.

Authors:  F L Graham; L Prevec
Journal:  Methods Mol Biol       Date:  1991

7.  Epidemiological characteristics and financial costs of the 1997 foot-and-mouth disease epidemic in Taiwan.

Authors:  P C Yang; R M Chu; W B Chung; H T Sung
Journal:  Vet Rec       Date:  1999 Dec 18-25       Impact factor: 2.695

8.  Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.

Authors:  M P Moraes; G A Mayr; P W Mason; M J Grubman
Journal:  Vaccine       Date:  2002-02-22       Impact factor: 3.641

9.  Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice.

Authors:  X Q Qin; N Tao; A Dergay; P Moy; S Fawell; A Davis; J M Wilson; J Barsoum
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

10.  Assay of bovine interferons in cultures of the porcine cell line IB-RS-2.

Authors:  R Ahl; A Rump
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

View more
  49 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle.

Authors:  Eva Perez-Martin; Marcelo Weiss; Fayna Diaz-San Segundo; Juan M Pacheco; Jonathan Arzt; Marvin J Grubman; Teresa de los Santos
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

3.  Anti-foot-and-mouth disease virus effects of Chinese herbal kombucha in vivo.

Authors:  Naifang Fu; Juncai Wu; Lv Lv; Jijun He; Shengjun Jiang
Journal:  Braz J Microbiol       Date:  2015-10-09       Impact factor: 2.476

4.  Engineering glycoprotein B of bovine herpesvirus 1 to function as transporter for secreted proteins: a new protein expression approach.

Authors:  Günther M Keil; Constanze Höhle; Katrin Giesow; Patricia König
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response.

Authors:  Teresa de Los Santos; Sonia de Avila Botton; Rudi Weiblen; Marvin J Grubman
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Robust Protection against Highly Virulent Foot-and-Mouth Disease Virus in Swine by Combination Treatment with Recombinant Adenoviruses Expressing Porcine Alpha and Gamma Interferons and Multiple Small Interfering RNAs.

Authors:  Su-Mi Kim; Jong-Hyeon Park; Kwang-Nyeong Lee; Se-Kyung Kim; Su-Hwa You; Taeseong Kim; Dongseob Tark; Hyang-Sim Lee; Min-Goo Seo; Byounghan Kim
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

7.  Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression.

Authors:  Fayna Diaz-San Segundo; Mauro P Moraes; Teresa de Los Santos; Camila C A Dias; Marvin J Grubman
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

8.  Evaluation of a DNA vaccine candidate co-expressing GP3 and GP5 of porcine reproductive and respiratory syndrome virus (PRRSV) with interferon α/γ in immediate and long-lasting protection against HP-PRRSV challenge.

Authors:  Yijun Du; Jing Qi; Yu Lu; Jiaqiang Wu; Dongwan Yoo; Xing Liu; Xiumei Zhang; Jun Li; Wenbo Sun; Xiaoyan Cong; Jianli Shi; Jinbao Wang
Journal:  Virus Genes       Date:  2012-07-28       Impact factor: 2.332

9.  Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo.

Authors:  Weizao Chen; Mingqiu Liu; Ye Jiao; Weiyao Yan; Xuefeng Wei; Jiulian Chen; Liang Fei; Yang Liu; Xiaoping Zuo; Fugui Yang; Yonggan Lu; Zhaoxin Zheng
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

10.  New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines.

Authors:  Teresa Rodríguez-Calvo; Samuel Ojosnegros; Marta Sanz-Ramos; Juan García-Arriaza; Cristina Escarmís; Esteban Domingo; Noemí Sevilla
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.